Home › Research › Topics › gray
gray
3 studies tagged gray, dated 2006-04-12 to 2025-03-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Cut-points and gray zones: The challenges of integrating Alzheimer's disease plasma biomarkers into clinical practice 2025-03-01
- Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia 2010-04-01
- Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex 2006-04-12
Studies
3 studies carry this tag.
Date range
2006 to 2025
Top journals
- Acta neuropathologica 1
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Neurology 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Plasma biomarkers for Alzheimer's disease (AD), such as plasma phosphorylated (p)-tau217, offer a more accessible means of testing for the presence of AD pathology compared to cerebrospinal fluid (CSF) or positron emission tomography (PET) methods.
-
The diffusivity of gray matter is increased in regions that are atrophic in frontotemporal dementia, suggesting disruption of the cytoarchitecture of remaining tissue.
-
40/100
Guam parkinsonism-dementia complex (PDC) is a neurodegenerative tauopathy in ethnic Chamorro residents of the Mariana Islands that manifests clinically with parkinsonism as well as dementia and is characterized neuropathologically by prominent cortical neuron loss in association with extensive telencephalic neurofibrillary tau pathology.